Dr. Reddy`s Laboratories Ltd
Research Dr. Reddy`s Laboratories Ltd (RDY) on Bullrun: market cap USD 10.68B, P/E 28.8, dividend yield 0.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRDY
- ExchangeNYSE
- CountryIndia
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 10.68B
- P/E28.8
- Dividend yield0.7%
- Financial periodQ1 2027
- RevenueINR 80.71B
- Net incomeINR 4.44B
- Gross margin46.5%
Valuation Snapshot
latest market cap is USD 10.68B; P/E is 28.8; dividend yield is 0.7%.
Peer valuation comparison
Latest P/E is 28.81x versus a Healthcare sector median of 24.67x (16.8% above).
Latest dividend yield is 0.65% versus a Healthcare sector median of 1.84% (64.7% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | INR 335.93B | INR 42.85B | INR 18.33B | 52.8% | 51.42 | INR 15.37B | INR 77.34B | INR 377.06B |
| FY2025 | INR 325.54B | INR 56.54B | INR 12.03B | 58.5% | 67.78 | INR 14.65B | INR 46.77B | INR 333.39B |
| FY2024 | INR 279.16B | INR 55.68B | INR 18.00B | 58.6% | 66.92 | INR 7.11B | INR 20.02B | INR 280.55B |
| FY2023 | INR 245.88B | INR 45.07B | INR 40.01B | 56.7% | 54.17 | INR 5.78B | INR 13.47B | INR 230.99B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 10.68B | 28.8 | 0.6% | 0.08 |
| 2025 | 2025-12-31 | USD 11.69B | 18.0 | 0.6% | 0.09 |
| 2024 | 2024-12-31 | USD 13.15B | 20.5 | 0.6% | 0.1 |
| 2023 | 2023-12-29 | USD 11.59B | 18.8 | 1.4% | 0.2 |
| 2022 | 2022-12-30 | USD 8.59B | 21.6 | 4.5% | 0.47 |
| 2021 | 2021-12-31 | USD 10.88B | 30.4 | 0.5% | 0.07 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.08 USD, yield 0.7%.
| Year | Dividends/share |
|---|---|
| FY2026 | 0.08 INR |
| FY2025 | 0.09 INR |
| FY2024 | 0.1 INR |
| FY2023 | 0.2 INR |
About Dr. Reddy`s Laboratories Ltd
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Dr. Reddy`s Laboratories Ltd's market cap?
Dr. Reddy`s Laboratories Ltd's market capitalization is USD 10.68B.
What is Dr. Reddy`s Laboratories Ltd's P/E ratio?
Dr. Reddy`s Laboratories Ltd's price-to-earnings (P/E) ratio is 28.8.
Does Dr. Reddy`s Laboratories Ltd pay a dividend?
Dr. Reddy`s Laboratories Ltd has a dividend yield of 0.7%.
What does Dr. Reddy`s Laboratories Ltd do?
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business.